Pharmafile Logo

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

With rapid growth comes growing pains…

- PMLiVE

The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.

Specific challenges facing the oncology field

1. Increased competition and evolving standard of care

New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.

With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.

Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…

Read the full article here.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Top 10 Tips for Running a Successful Virtual Event

As I explored in a recent article previously published on Pharmaphorum, the ways that pharmaceutical and scientific communities attend meetings and events completely changed in 2020. Virtual events are rapidly improving, as...

Removing Barriers to Pharmaceutical Accessibility & Affordability Worldwide

Dr. Dhiren Thakker, Founding President and CEO at Med Aditus, shares his insights into how blockchain and other leading-edge technologies can help revolutionize pharmaceutical manufacturing in sub-Saharan Africa and globally....

Top 10 Most Common Participant Comments – Online Advisory Boards

What advisors and participants have to say about the Impetus InSite Platform!

Top 10 Ways that Medical Affairs Team Can Leverage the Impetus Insite Platform

New to asynchronous touchpoints? Don’t know where to start? Need help designing an asynchronous event that will engage your stakeholders and give you the insights you’re looking for? In addition...

Digitalizing Self-Care to Empower Patients

Jonathon Carr-Brown, Chief Operating Officer at Healthily, shares how they are redefining the relationship between retailers and over-the-counter pharmaceutical companies with their customers, and how a digitally-enabled Pre-Primary Care Health...

Upcoming webinars on March 22, 23, 24 – virtual product launches and pre-launch planning

Grab your beverage of choice and join us! This month, we’re diving into virtual product launches and pre-launch planning.

Virtual Product Launch Planning & Preparation: A Customer Story

For this Pre-Product Launch Longitudinal Expert Engagement Plan™ (LEEP™), our client leveraged Impetus Digital’s cutting-edge virtual tools, comprehensive online platform, and White-Glove™ digital and strategic services to engage a group...

Top 10 Tips to Increase Engagement During Virtual Events

If you are a member of the Medical Affairs Professional Society (MAPS), you might have caught our popular webinar on how COVID-19 has impacted (and will continue to impact) live...

Consumer-driven Healthcare in the Digital Age

Dr. Gil Blander, Co-founder & Chief Scientific Officer at InsideTracker, explores consumer-driven healthcare, the use of big data and AI for creating personalized health protocols, the trillion-dollar “longevity economy,” and...

Virtual collaboration tools to reduce “digital overload”

Considering its impact on our health and productivity, digital overload is clearly something that we need to take seriously.